Episodes
-
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle
April 21st, 2020 | 22 mins 4 secs
dr neil love, research to practice
Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations.
-
COVID-19 and Prostate Cancer
April 9th, 2020 | 16 mins 16 secs
dr neil love, research to practice
COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor.